V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007641 | 330004473 | 1.71 | 64.7 | Curative (C) | 2014-09-09 | 2014-09-19 | VAI (Ifos 3g/m2) | 02 | null | 330012138 | VAI |
| 330007642 | 330008439 | null | 59 | Disease modification (D) | 2016-02-06 | 2016-02-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012139 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007643 | 330004474 | 0 | null | Neo-adjuvant (N) | 2016-04-17 | 2016-04-23 | Cetuximab + Radiotherapy Load | 02 | N | 330012143 | CETUXIMAB + RT |
| 330007644 | 330004475 | 1.77 | 78.4 | Palliative (P) | 2017-03-30 | 2017-04-06 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012144 | CARBOPLATIN + ETOPOSIDE |
| 330007645 | 330004476 | 0 | null | Palliative (P) | 2016-05-14 | 2016-05-21 | CARBOPLATIN + PACLITAXEL | 02 | N | 330012145 | CARBOPLATIN + PACLITAXEL |
| 330007646 | 330010575 | null | 69.8 | Curative (C) | 2014-06-21 | 2014-06-21 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330012148 | CARBOPLATIN + ETOPOSIDE |
| 330007647 | 330004477 | 1.8 | null | Palliative (P) | 2016-06-13 | 2016-06-26 | Paclitaxel 80mg/m2 day 1 8 15 | N | Y | 330012150 | PACLITAXEL |
| 330007648 | 330008441 | 1.78 | 68 | Curative (C) | 2016-12-03 | 2017-03-30 | Paclitaxel (2 or 3 weekly) | N | Y | 330012152 | PACLITAXEL |
| 330007649 | 330010576 | 1.02 | null | Curative (C) | null | 2016-01-30 | CARBOPLATIN + RT | Y | null | 330012154 | CARBOPLATIN + RT |
| 330007650 | 330011766 | 1.48 | 72 | Curative (C) | 2015-05-28 | 2015-06-04 | CARBOPLATIN + RT | 02 | Y | 330012159 | CARBOPLATIN + RT |
| 330007651 | 330004478 | 1.84 | 67.7 | Curative (C) | 2017-02-02 | 2017-02-06 | CARBOPLATIN + RT | N | N | 330012165 | CARBOPLATIN + RT |
| 330007652 | 330010577 | 0 | 57.9 | Curative (C) | 2013-03-27 | 2013-03-27 | Cetuximab + Radiotherapy Maint | N | N | 330012168 | CETUXIMAB + RT |
| 330007653 | 330004479 | null | 60 | Curative (C) | 2016-02-26 | 2016-02-26 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330012168 | CARBOPLATIN + PACLITAXEL |
| 330007654 | 330004479 | 1.6 | null | Palliative (P) | 2018-05-13 | 2018-06-07 | CARBOPLATIN + PACLITAXEL | 2 | Y | 330012168 | CARBOPLATIN + PACLITAXEL |
| 330007655 | 330004481 | 1.8 | 46 | Adjuvant (A) | 2018-07-12 | 2018-07-12 | PACLITAXEL | N | Y | 330012172 | PACLITAXEL |
| 330007656 | 330004482 | 1.6 | 121.2 | Curative (C) | 2018-07-01 | 2018-07-23 | ALL UKALL2011 (ProtM-A) C PegAsp | 02 | N | 330012176 | UKALL2011 |
| 330007657 | 330004483 | 1.78 | 63.2 | Palliative (P) | null | 2015-03-20 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 330012178 | CARBO + FLUOROURACIL |
| 330007658 | 330004484 | 1.7 | 109 | Not known (9) | 2014-11-11 | 2015-02-04 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012188 | CARBOPLATIN + ETOPOSIDE |
| 330007659 | 330004485 | 1.77 | null | null | 2014-08-06 | 2014-09-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 330012190 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007660 | 330004485 | null | 59 | Curative (C) | null | 2015-08-07 | EURAMOS TRIAL | 02 | Y | 330012190 | EURAMOS TRIAL |
| 330007661 | 330004485 | 1.5 | null | Curative (C) | 2013-06-18 | 2013-06-19 | BENDAMUSTINE + RITUXIMAB | N | N | 330012190 | BENDAMUSTINE + RITUXIMAB |
| 330007662 | 330004487 | 1.43 | 78.9 | Curative (C) | null | 2015-09-14 | ALL UKALL2011 Maintenance A1 | N | N | 330012203 | UKALL2011 |
| 330007663 | 330004490 | 1.59 | null | Neo-adjuvant (N) | 2018-02-15 | 2018-02-16 | CETUXIMAB + RT | 02 | N | 330012213 | CETUXIMAB + RT |
| 330007664 | 330004490 | 1.7 | null | Curative (C) | 2013-07-29 | 2013-06-09 | Bendamustine+Rituximab (1st Course) | 02 | N | 330012213 | BENDAMUSTINE + RITUXIMAB |
| 330007665 | 330004492 | 1.73 | 56.5 | Palliative (P) | 2018-04-28 | 2018-05-05 | Carboplatin + Paclitaxel (weekly) | 02 | N | 330012218 | CARBOPLATIN + PACLITAXEL |
| 330007666 | 330004493 | 1.81 | 84.1 | Neo-adjuvant (N) | 2014-08-27 | 2014-08-31 | Paclitaxel Priming | N | null | 330012224 | PACLITAXEL |
| 330007667 | 330008450 | 1.8 | 83.8 | Palliative (P) | 2018-01-21 | 2018-03-09 | Carboplatin + Paclitaxel (3 weekly) | 2 | null | 330012228 | CARBOPLATIN + PACLITAXEL |
| 330007668 | 330004494 | null | 83.3 | Palliative (P) | 2015-04-20 | 2015-04-21 | CARBOPLATIN + PACLITAXEL | N | N | 330012228 | CARBOPLATIN + PACLITAXEL |
| 330007669 | 330004495 | 1.78 | 81 | null | 2014-03-16 | 2014-03-16 | EURAMOS TRIAL | N | N | 330012233 | EURAMOS TRIAL |
| 330007670 | 330008452 | 1.65 | 63.3 | Curative (C) | 2016-03-10 | 2016-04-01 | Bendamustine+Rituximab (1st Course) | 02 | N | 330012237 | BENDAMUSTINE + RITUXIMAB |
| 330007673 | 330004500 | 1.63 | 59.4 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-03 | Paclitaxel (2 or 3 weekly) | N | N | 330012256 | PACLITAXEL |
| 330007674 | 330010581 | null | 87.5 | Neo-adjuvant (N) | null | 2017-09-20 | EURAMOS TRIAL | null | null | 330012256 | EURAMOS TRIAL |
| 330007675 | 330012810 | 1.83 | null | Palliative (P) | null | 2013-10-23 | Carboplatin + Paclitaxel (weekly) | N | N | 330012261 | CARBOPLATIN + PACLITAXEL |
| 330007676 | 330008455 | null | null | Neo-adjuvant (N) | 2016-03-27 | 2017-05-18 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330012262 | CARBOPLATIN + PACLITAXEL |
| 330007677 | 330004502 | 0 | 77.4 | Palliative (P) | 2015-09-24 | 2015-10-03 | Paclitaxel (2 or 3 weekly) | N | N | 330012271 | PACLITAXEL |
| 330007678 | 330004502 | 1.7 | 95.8 | Palliative (P) | 2018-11-19 | 2018-11-23 | Paclitaxel (2 or 3 weekly) | 02 | Y | 330012271 | PACLITAXEL |
| 330007679 | 330008457 | 0 | 86 | Adjuvant (A) | 2014-04-26 | 2014-04-26 | VAI (Ifos 3g/m2) | Y | N | 330012275 | VAI |
| 330007680 | 330004505 | 1.71 | 65.9 | Curative (C) | 2013-06-04 | 2013-12-15 | Cetuximab + Radiotherapy Load | 2 | N | 330012277 | CETUXIMAB + RT |
| 330007681 | 330004507 | 1.7 | 61.7 | Curative (C) | 2017-03-13 | 2017-03-13 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330012285 | CARBOPLATIN + PACLITAXEL |
| 330007682 | 330004508 | 1.68 | 63.15 | Neo-adjuvant (N) | 2013-10-12 | 2013-10-19 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 330012287 | BENDAMUSTINE + RITUXIMAB |
| 330007683 | 330004510 | 1.84 | 78.8 | Neo-adjuvant (N) | 2013-05-20 | 2013-06-24 | EURAMOS TRIAL | 02 | N | 330012287 | EURAMOS TRIAL |
| 330007684 | 330004511 | 1.83 | 57 | Neo-adjuvant (N) | 2016-01-16 | 2016-01-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012294 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007685 | 330004512 | 1.69 | 65.7 | Neo-adjuvant (N) | 2016-11-10 | 2016-11-15 | Cetuximab + Radiotherapy Maint | 2 | N | 330012294 | CETUXIMAB + RT |
| 330007686 | 330004513 | 1.68 | 107.8 | Neo-adjuvant (N) | 2013-10-19 | 2014-03-18 | EURAMOS TRIAL | N | null | 330012305 | EURAMOS TRIAL |
| 330007687 | 330004517 | 1.74 | 103.5 | Curative (C) | 2015-05-05 | 2015-05-05 | CARBOPLATIN + RT | N | N | 330012305 | CARBOPLATIN + RT |
| 330007688 | 330004517 | 0 | 139 | Neo-adjuvant (N) | 2016-02-08 | 2016-02-14 | CARBO + FLUOROURACIL | N | N | 330012305 | CARBO + FLUOROURACIL |
| 330007689 | 330004517 | 1.79 | 85.4 | Curative (C) | 2016-10-09 | 2016-10-08 | BENDAMUSTINE + RITUXIMAB | Y | N | 330012305 | BENDAMUSTINE + RITUXIMAB |
| 330007690 | 330004518 | 1.69 | 50.7 | Palliative (P) | null | 2013-07-04 | ALL UKALL2011 Maintenance C1 | Y | null | 330012324 | UKALL2011 |
| 330007691 | 330004521 | 1.55 | 52.5 | null | 2016-05-19 | 2016-05-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330012329 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007692 | 330004522 | null | 74.8 | Neo-adjuvant (N) | 2015-06-20 | 2015-06-24 | BENDAMUSTINE + RITUXIMAB | N | N | 330012332 | BENDAMUSTINE + RITUXIMAB |